Victory Capital Management
ELOX

Victory Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Victory Capital Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-270
Closed -$8K – 2853
2021
Q4 		$8K Sell
270
-8
-3% -$349 ﹤0.01% 2741
2021
Q3 		$18K Sell
278
-31
-10% -$1.91K ﹤0.01% 2733
2021
Q2 		$25K Buy
+309
New +$25.8K ﹤0.01% 2695
2020
Q2 		– Sell
-194
Closed -$16K – 3533
2020
Q1 		$16K Buy
+194
New +$31.6K ﹤0.01% 3188
2019
Q4 		– Sell
-94
Closed -$17K – 3517
2019
Q3 		$17K Buy
+94
New +$26.7K ﹤0.01% 3107

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Victory Capital Management's ELOX Position: Q1 2022 in Review

Victory Capital Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2022, closing a stake of 270 shares — an estimated $8K sold.

Victory Capital Management first reported a position in ELOX in Q3 2019 and held it in 5 quarters. The position peaked at $25K in Q2 2021. 35 funds tracked by Wall St. Rank hold ELOX as of Q1 2022.

  • Victory Capital Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 270 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $8K.
  • Victory Capital Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Victory Capital Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $25K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.